Tien Liang BioTech Co., Ltd.

NT$33.05As of Sun 8 Nov 2026, 12:00 UTC
TPEx:4127Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 6.95%
Div yield —
ROE 14.25%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.95
PE TTM 21.89
TSR TTM 3.28%
Mkt cap NT$1.512B
ROIC 0.61%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$36
8.17%
(50.68%)
Hold 0|12|1|1|3
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.43
0.49
0.47
0.45
7.49%
13.33%
8.93%
(1.87%)
RevenueNT$M
101.7
105.4
106.2
103.7
9.07%
8.65%
4.69%
0.28%
Peers (US$45.68M)
Cap (US$)
PE
59.32M
22.19x
45.46M
—
Capital
TTM
5Y
10Y
Leveragex
0.793
0.216
0.136
EBIT/Intx
1.197
0.310
0.252
Own earn%
(111.73)
12.96
20.41
Sh yield%
7.23
47.33
38.77
Owners
Insiders/Inst%
6.87
79.80
Short interest%
2.39
SBC / revenue%
1.57
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
12–17
$1 testx
—
Incr. ROIC%
18